Literature DB >> 7124630

Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.

M D Winniford, R V Markham, B G Firth, P Nicod, L D Hillis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7124630     DOI： 10.1016/0002-9149(82)91222-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  20 in total

1.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.

Authors:  O Visioli; R Bolognesi; F Cucchini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 4.  Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; C F George
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

5.  Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise.

Authors:  M R Wilkins; K L Woods; D B Jack; M J Kendall; S J Laugher
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.

Authors:  B Silke; S P Verma; G I Nelson; M Hussain; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

Review 7.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

8.  The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.

Authors:  M B Maltz; D W Davies; C P Lau; J E Creamer; S O Banim; A J Camm
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

9.  Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.

Authors:  P A Woodmansey; A G Stewart; A H Morice; K S Channer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.

Authors:  S Motomura; K Hashimoto
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.